Sidea Semiconductor Equipment
301629
Wintech Nano
688757
Guangdong Xinyaguang Cable
001382
Jiangxi Jiangnan New Material Technology
603124
Hefei Hengxin Life Science and Technology
301501
CN Stock MarketDetailed Quotes
002773 Chengdu Kanghong Pharmaceutical Group
- 21.88
- 0.000.00%
Not Open Mar 25 09:30 CST
20.12BMarket Cap16.87P/E (TTM)
0.00High0.00Low0lotVolume0.00Open21.88Pre Close0.00Turnover0.00%Turnover Ratio19.26P/E (Static)919.78MShares24.5052wk High2.39P/B15.00BFloat Cap16.3452wk Low24.07Limit Up685.34MShs Float52.71Historical High19.69Limit Down0.00%Amplitude6.72Historical Low0.38Dividend TTM--Avg Price0lotAsk1.74%Div YieldTTM100Lot Size0lotBid
Chengdu Kanghong Pharmaceutical Group News
Kanghong Pharmaceutical: Announcement on the Company\'s Receipt of the Drug Clinical Trial Approval Notice
Kanghong Pharmaceutical: Announcement on Using Own Funds to Purchase Wealth Management Products
Kanghong Pharmaceutical: Announcement on Using Own Funds to Purchase Wealth Management Products
Kanghong Pharmaceutical: Announcement on Using Own Funds to Purchase Wealth Management Products
Kanghong Pharmaceutical: Announcement on the resignation of the company\'s senior management
Kanghong Pharmaceutical: Announcement on the company\'s participation in the national centralized procurement of drugs to win the bid
Kanghong Pharmaceutical: Announcement on the Company\'s receipt of a drug registration certificate
Kanghong Pharmaceutical: Announcement on the Company\'s receipt of a drug registration certificate
Kanghong Pharmaceutical: Announcement on the Company\'s receipt of a drug registration certificate
Kanghong Pharmaceutical: Announcement on the Company\'s Receipt of the Drug Clinical Trial Approval Notice
Kanghong Pharmaceutical: Announcement on Using Own Funds to Purchase Wealth Management Products
Kanghong Pharmaceutical: Announcement on the resignation of the company\'s senior management
Kanghong Pharmaceutical: Announcement on Using Own Funds to Purchase Wealth Management Products
Chengdu Kanghong Pharmaceutical Group: Financial Report for the first half of 2024.
Chengdu Kanghong Pharmaceutical Group: Interim financial statements.
Chengdu Kanghong Pharmaceutical Group: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Chengdu Kanghong Pharmaceutical Group: Announcement Regarding the Company's Receipt of Pharmaceutical Registration Certificate.
Chengdu Kanghong Pharmaceutical Group: Announcement regarding the subsidiary receiving notification of approval for the listing application of chemical raw materials.
Chengdu Kanghong Pharmaceutical Group: Announcement regarding the subsidiary receiving notification of approval for the listing application of chemical raw materials.
Chengdu Kanghong Pharmaceutical Group: Announcement regarding the completion of commercial registration changes and the revision of the company's articles of association.
